BD Biosciences/APC Mouse Anti-Human IL-2/5 μL/341116,BD Biosciences,,BD Biosciences,bdbiosciences,+,,Array.Array.Array蚂蚁淘厂家直采.

产品名称：BD Biosciences/APC Mouse Anti-Human IL-2/5 μL/341116

产品编号：341116

市场价：¥11548.53

场地：美国(厂家直采)

产品分类：蛋白类>多肽>多肽合成>

联系QQ：1570468124

电话号码：4000-520-616

邮箱： info@ebiomall.com

美元价：$549.93

品牌： BD Biosciences

公司：BD Biosciences,Inc.

公司分类：

商品介绍

Product DetailsRecommended AssayReferences

Description

Anti-Hu–IL-2, clone 5344.111, is derived from a fusion of Sp2/0 myeloma cells with splenocytes from BALB/c mice immunized with recombinant human IL-2.

Anti-Human Interleukin-2 (Anti-Hu–IL-2) recognizes a 15- to 18-kilodalton (kd) glycoprotein.

Format

FormatAPC
Excitation SourceRed 633 nm
Excitation Max650nm
Emission Max660nm

Allophycocyanin (APC), is an accessory photosynthetic pigment found in blue-green algae. Its molecular weight is approximately 105 kDa. APC has six phycocyanobilin chromophores per molecule, which makes it a very bright fluorochrome that is highly suitable for flow cytometry applications. Due to nearly identical excitation and emission properties but different spillover characteristics, APC and Alexa Fluor® 647 cannot be used simultaneously

Other Formats→

FITC

Resources & Tools
Spectrum Viewer	Panel Designer	SpectrumViewer	Download MSDS	Download TDS

Preparation and Storage

The FITC conjugate is supplied as 12.5 µg in 1.0 mL (12.5 µg/mL) of PBS. The PE conjugate is supplied as 1.6 µg in 1.0 mL (1.6 µg/mL) of PBS. The APC conjugate is supplied as 3 µg in 0.5 mL (6 µg/mL) of PBS. PBS contains gelatin and 0.1% sodium azide.

Store vials at 2°C–8°C. Conjugated forms should not be frozen. Protect from exposure to light. Each reagent is stable until the expiration date shown on the bottle label when stored as directed.

Aggarwal BB, Puri RK. Common and uncommon features of cytokines and cytokine receptors: an overview. In: Human Cytokines: Their Role in Disease and Therapy. Cambridge, MA: Blackwell Science; 1995:3-24.
Clerici M, Hakim FT, Venzon DJ, et al. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest. 1993;91:759-765.
Clerici M, Shearer GM. A T_H1 → T_H2 switch is a critical step in the etiology of HIV infection. Today. 1993;14:107-110.
Cook EB, Stahl JL, Lowe L, et al. Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs non-allergics. J Immmol Meth. 2001;254:109-118.
Croft M, Carter L, Swain S, Dutton RW. Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting Type 2 versus Type 1 cytokine profiles. J Exp Med. 1994;180:1715-1728.
ElGhazali GEB, Paulie S, Andersson G, et al. Number of interleukin-4– and interferon- γ –secreting human T cells reactive with tetanus toxoid and the mycobacterial antigen PPD or phytohemagglutinin: distinct response profiles depending on the type of antigen used for activation. Eur J Immunol. 1993;23:2740-2745.
Elson LH, Nutman TB, Metcalfe DD, Prussin C. Flow cytometric analysis for cytokine production identifies T helper 1, T helper 2, and T helper 0 cells within the human CD4⁺ CD27^- lymphocyte subpopulation. J Immunol. 1995;154:4294-4301
Graves JD, Downward J, Izquierdo-Pastor M, Rayter S, Warne PH, Cantrell DA. The growth factor IL-2 activates p21^ras proteins in normal human lymphocytes. J Immunol. 1992;148:2417-2422.
Graziosi C, Pantaleo G, Gantt KR, et al. Lack of evidence for the dichotomy of T H 1 and T H 2 predominance in HIV-infected individuals. Science. 1994;265:248-252.
Gusella GL, Musso T, Bosco MC, Expinoza-Delgado I, Matsushima K, Varesio L. IL-2 upregulates but IFN-γ suppresses IL-8 expression in human monocytes. J Immunol. 1993;151:2725-2732.
Hillman GG, Haas GP. Role of cytokines in lymphocyte functions. Human Cytokines: Their Role in Disease and Therapy. 1995:37-54.
Hyjek E, Lischner HW, Hyslop T, et al. Cytokine patterns during progression to AIDS in children with perinatal HIV infection. J Immunol. 1995;155:4060-4071.
Lanier LL, Benike CJ, Phillips JH, Engleman EG. Recombinant interleukin-2 enhanced natural killer cell– mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu-7 and Leu-11 antigens. J Immunol. 1985;134:794-801.
Maggi EM, M, Ravina A, Annunziato F, et al. Ability of HIV to promote a T H 1 to T H 0 shift and to replicate preferentially in T_H2 and T_H0 cells. Science. 1994;265:244-248.
Musso T, Espinoza-Dalgado I, Pullki K, Gusella G, Longo D, Varesio L. IL-2 induces IL-6 production in human monocytes. J Immunol. 1992;148:795-800.
Openshaw P, Murphy EE, Hosken NA, et al. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J Exp Med. 1995;182:1357-1367.
Phillips JH, Gemlo BT, Myers WW, Rayner AA, Lanier LL. In vivo and in vitro activation of natural killer cells in advanced cancer patients undergoing combined recombinant interleukin-2 and LAK cell therapy. J Clin Oncology. 1987;5:1933-1941.
Picker LJ, Singh MK, Zdraveski Z, et al. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood. 1995;86:1408-1419.
Röcken M, Müller KM, Saurat J-H, et al. Central role for TCR/CD3 ligation in the differentiation of CD4⁺ T cells toward a TH₁ or TH₂ functional phenotype. J Immunol. 1992;148:1031-1036.
Röcken M, Saurat J-H, Hauser C. A common precursor for CD4⁺ T cells producing IL-2 or IL-4. J Immunol. 1992;148:47-54.
Street NE, Mosmann TR. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J. 1991;5:171-176.
Suni MA, Picker LJ, Maino VC. Detection of antigen-specific T cell cytokine expression in whole blood by flow cytometry. J Immunol Methods. 1998;212:89-98.
Zhang X, Giangreco L, Broome E, Dargan CM, Swain SL. Control of CD4 effector fate: transforming growth factor β 1 and interleukin-2 synergize to prevent apoptosis and promote effector expansion. J Exp Med. 1995;182:669-709.

品牌介绍

BD是世界上最大的生产和销售医疗设备、医疗系统和试剂的医疗技术公司之一。致力于提高全世界人类的健康水平。BD专注于改进药物治疗，提高传染性疾病诊断的质量和速度，推进新型药物和疫苗的研究与发现。公司于1897年在纽约成立，总部位于美国新泽西州的富兰克林湖，业务可分为BD医疗、BD诊断、BD生物科学三大类，生产销售包括医用耗材、实验室仪器、抗体、试剂、诊断等产品。

公司介绍

更多...

产品分类

更多...